127 related articles for article (PubMed ID: 1694860)
1. Fatty acid chain is a critical epitope for antiphospholipid antibody.
Levy RA; Gharavi AE; Sammaritano LR; Habina L; Lockshin MD
J Clin Immunol; 1990 May; 10(3):141-5. PubMed ID: 1694860
[TBL] [Abstract][Full Text] [Related]
2. Bacterial immunity and immunogenesis of normal human salivary IgA and serum IgG2 antiphospholipid autoantibody: a link?
Cheng HM; Sam CK
Immunol Lett; 1990 Oct; 26(1):7-10. PubMed ID: 2276764
[TBL] [Abstract][Full Text] [Related]
3. Anti-phospholipid antibody isotypes in normal human sera.
Cheng HM; Wong KK
Immunol Lett; 1990 Jan; 23(3):183-6. PubMed ID: 2307490
[TBL] [Abstract][Full Text] [Related]
4. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil HP; Simpson RJ; Chesterman CN; Krilis SA
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4120-4. PubMed ID: 2349221
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.
Sammaritano LR; Gharavi AE; Soberano C; Levy RA; Lockshin MD
J Clin Immunol; 1992 Jan; 12(1):27-35. PubMed ID: 1372614
[TBL] [Abstract][Full Text] [Related]
6. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders.
Harris EN; Gharavi AE; Wasley GD; Hughes GR
J Infect Dis; 1988 Jan; 157(1):23-31. PubMed ID: 3335805
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
[TBL] [Abstract][Full Text] [Related]
9. The elongation of exogenous fatty acids and the control of phospholipid acyl chain length in Micrococcus cryophilus.
Sandercock SP; Russell NJ
Biochem J; 1980 Jun; 188(3):585-92. PubMed ID: 7470022
[TBL] [Abstract][Full Text] [Related]
10. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.
Exner T; McRea J
Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389
[TBL] [Abstract][Full Text] [Related]
11. Differential binding of antiphospholipid autoantibody in normal and autoimmune sera to prothrombin/phospholipid antigen complex.
Cheng HM
Blood; 1994 Feb; 83(4):1157-8. PubMed ID: 8111059
[No Abstract] [Full Text] [Related]
12. Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity.
Celli CM; Gharavi AE; Chaimovich H
Biochim Biophys Acta; 1999 Jan; 1416(1-2):225-38. PubMed ID: 9889373
[TBL] [Abstract][Full Text] [Related]
13. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
14. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.
Cabral AR; Amigo MC; Cabiedes J; Alarcon-Segovia D
Am J Med; 1996 Nov; 101(5):472-81. PubMed ID: 8948270
[TBL] [Abstract][Full Text] [Related]
15. Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin.
Giles IP; Haley J; Nagl S; Latchman DS; Chen PP; Chukwuocha RU; Isenberg DA; Rahman A
Mol Immunol; 2003 Sep; 40(1):49-60. PubMed ID: 12909130
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds.
Qamar T; Gharavi AE; Levy RA; Lockshin MD
J Clin Immunol; 1990 Jul; 10(4):200-3. PubMed ID: 2211960
[TBL] [Abstract][Full Text] [Related]
17. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens.
Giles I; Lambrianides N; Pattni N; Faulkes D; Latchman D; Chen P; Pierangeli S; Isenberg D; Rahman A
J Immunol; 2006 Aug; 177(3):1729-36. PubMed ID: 16849482
[TBL] [Abstract][Full Text] [Related]
18. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
19. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi AE; Harris EN; Asherson RA; Hughes GR
Ann Rheum Dis; 1987 Jan; 46(1):1-6. PubMed ID: 3813670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
